Use of Cancer Drugs

Project Title Use of Cancer Drugs
Date Posted
Friday, December 8, 2017
Project ID
str_wp032_nsdp_v01, str_wp033_nsdp_v01, str_wp034_nsdp_v01, str_wp035_nsdp_v01
Status
In progress
Deliverables
Sentinel Summary Table Report: Use of Cancer Drugs (HCPCS)
Sentinel Summary Table Report: Use of Cancer Drugs (Prevalent Use)
Description

This request examines the incidence, prevalence, and occurrence of various Healthcare Common Procedure Coding System (HCPCS) codes for intravenous cancer drugs in the Sentinel Distributed Database (SDD).

Medical Product
crizoatinib
erlotinib HCL
ipilimumab
nivolumab
pembrolizumab
Population / Cohort
All individuals
Time Period
January 1, 2000 - August 31, 2015
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Sentinel Distributed Database (SDD)
FDA Center
CDER
Scroll to Top